Sponsored Webcast: Breaking Through The Nams Noise: Impact Of FDA's Roadmap On Nams For Drug Safety Testing (On Demand)

On-demandOn-demand Member: $0 | Nonmember: $50 Biologics/ biosimilars/ vaccinesCombination products/companion diagnosticsIntermediatePharmaceuticalsPreclinical studyRegulatory Intelligence/PolicyResearch, Design and DevelopmentUnited States